You are viewing: North America In Vitro Fertilization Market analysis
Part of: In Vitro Fertilization Market (Global)

The North America In Vitro Fertilization Market was valued at $215.5 Million in 2024 and projected to reach to $361.9 Million by 2029, representing a compound annual growth rate of 10.9%. North America's In Vitro Fertilization market is positioned for sustained expansion through 2029, driven by demographic shifts, delayed childbearing trends, and rising infertility rates.

North America In Vitro Fertilization Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

North America In Vitro Fertilization Market Trends and Insights

  • North America's advanced healthcare infrastructure, high adoption of assisted reproductive technologies, and increasing awareness of fertility treatments are driving this expansion.
  • The region benefits from strong regulatory frameworks, established clinical networks, and significant investment in reproductive health innovation. In North America, rising infertility rates, delayed childbearing trends, and improved insurance coverage for fertility treatments are key growth catalysts.
  • North America's market is characterized by high treatment costs offset by better reimbursement policies compared to other regions.
  • The forecast period through 2029 reflects North America's commitment to expanding access to IVF services and technological advancements in embryo selection and cryopreservation techniques..

Key Market Statistics

  • CAGR (2024-2029) 10.9% CAGR
  • Market Size, 2024 ~USD 215.5 Million
  • Forecast, 2029 ~USD 361.9 Million
  • Geography North America

North America In Vitro Fertilization Market Overview

Market Valuation & Growth :

North America's IVF market is valued at $215.5 million in 2024, with a robust 10.9% CAGR projected through 2029, reaching $361.9 million. This growth outpaces many global regions, driven by increasing demand for assisted reproductive technologies.

Advanced Healthcare Infrastructure :

The region benefits from state-of-the-art medical facilities, cutting-edge reproductive technology, and highly trained fertility specialists. North America's healthcare ecosystem supports rapid adoption of innovative IVF treatments and procedures.

High Treatment Awareness & Adoption :

Increasing awareness of fertility treatment options, coupled with growing acceptance of assisted reproductive technologies, has expanded the patient base. Insurance coverage improvements and reduced stigma are driving higher treatment uptake across North America.

Strong Regulatory Framework :

North America maintains robust regulatory standards that ensure treatment safety and efficacy. Clear guidelines from health authorities provide confidence to patients and practitioners, supporting market expansion and consumer trust.

North America In Vitro Fertilization Market Dynamics

  • The region's mature healthcare system and strong reimbursement landscape create favorable conditions for market growth.
  • Technological advancements in embryo selection and personalized treatment protocols are enhancing success rates and patient outcomes. Key growth catalysts include increasing insurance coverage for fertility treatments, growing medical tourism within the region, and rising consumer spending on reproductive health.
  • The market will benefit from expanding clinic networks, improved accessibility in underserved areas, and heightened public awareness campaigns.
  • Strategic partnerships between fertility centers and healthcare providers are expected to accelerate market penetration and drive the projected growth to $361.9 million by 2029..

Related Ecosystem

In Vitro Diagnostics

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Dna Microarrays
  • Assay Kits
  • Microarrays
Top Companies
  • ROCHE HOLDINGS AG
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Biomerieux s.a.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • CONMED Corporation

      Key Takeaways

      • North America's IVF market is valued at $215.5 million in 2024 and will reach $361.9 million by 2029, representing a 10.9% CAGR.
      • North America leads in IVF adoption due to advanced healthcare infrastructure, strong regulatory support, and established fertility clinic networks.
      • Rising infertility rates and delayed childbearing in North America are primary drivers of market expansion through 2029.
      • North America's improved insurance coverage and reimbursement policies differentiate the region from global markets and support sustained growth.

      In Vitro Fertilization Market Report Scope

      Report Metric Details
      Base Year 2024
      Fastest Growing Segment FROZEN NON-DONORS (Type)
      Forecast Period 2024-2029
      Growth Rate CAGR of 11.7% from 2024 to 2029
      Largest Segment EQUIPMENT (Product)
      Market Size Base Year (Billions) ~USD 0.95 (2024)
      Revenue Forecast (Billions) ~USD 1.65 (2029)
      Segments Covered Product, Type, Type Of Cycle, Procedure, End User

      North America In Vitro Fertilization Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Product

      • Accessories
      • Anti-Vibration Tables
      • Cabinets
      • Cryosystems
      • Equipment
      • Gas Analyzers
      • Imaging Systems
      • Incubators
      • Laser Systems
      • Micromanipulator Systems
      • Microscopes
      • Other Equipment
      • Ovum Aspiration Pumps
      • Reagents & Media
      • Sperm Analyzer Systems
      • Sperm Separation Systems
      • Witness Systems

      By Type

      • Anti-Vibration Tables
      • Cabinets
      • Cryopreservation Media
      • Cryosystems
      • Embryo Culture Media
      • Gas Analyzers
      • Imaging Systems
      • Incubators
      • Laser Systems
      • Micromanipulator Systems
      • Microscopes
      • Other Equipment
      • Other Incubators
      • Ovum Aspiration Pumps
      • Ovum Processing Media
      • Sperm Analyzer Systems
      • Sperm Processing Media
      • Sperm Separation Systems
      • Time-Lapse Incubators
      • Witness Systems

      By Type Of Cycle

      • Fresh Donors
      • Fresh Non-Donors
      • Frozen Donors
      • Frozen Non-Donors

      By Procedure

      • Conventional Ivf
      • Ivf With Donar Eggs
      • Ivf With Icsi
      • Minimal Ivf
      • Other Procedures

      By End User

      • Cryobanks
      • Fertility Clinics & Ivf Centers
      • Hospitals & Surgical Centers
      • Hospitals & Surgical Clinics
      • Research Institutes

      Target Audience

      • Fertility Clinic Operators : Clinic owners and administrators need regional market data to optimize service offerings, plan facility expansions, and identify geographic markets with highest growth potential in North America.
      • Medical Device & Pharmaceutical Companies : Manufacturers of IVF equipment, medications, and diagnostic tools require market insights to guide product development, commercialization strategies, and regional sales planning for North America.
      • Healthcare Investors & PE Firms : Investment professionals evaluating fertility sector opportunities need comprehensive North American market analysis to assess valuations, growth prospects, and acquisition targets in the IVF space.
      • Insurance & Reimbursement Providers : Payers and insurance companies need market data to understand treatment demand, cost structures, and coverage trends to develop competitive fertility benefit programs across North America.
      • Healthcare Consultants & Strategists : Consulting firms advising healthcare organizations require detailed North American IVF market intelligence to support client strategy development, market entry planning, and competitive positioning.

      North America vs. other regions

      HowNorth America compares to the other 3 regional blocs covered in this market.

      Europe
      ~USD 504.7 Million · 11.7% wtd CAGR ·
      Asia Pacific
      ~USD 634.5 Million · 12.8% wtd CAGR ·
      Latin America
      ~USD 96.4 Million · 9.8% wtd CAGR ·
      Middle East & Africa
      ~USD 53 Million · 8.7% wtd CAGR ·

      Countries within North America - compare and drill down

      Country2025 size (native)
      USUSD 328.6 Million
      CanadaUSD 33.2 Million
      MexicoUSD 18.1 Million

      Country market size visualization

      US
      USD 328.6 Million
      Canada
      USD 33.2 Million
      Mexico
      USD 18.1 Million

      Reasons to Buy this Report

      • Regional Market Sizing & Forecasts : Obtain precise market valuations for North America's IVF sector with detailed 2024-2029 projections. Understand regional growth trajectories and identify investment opportunities with confidence.
      • Country-Level Breakdown : Access granular data for US, Canada, and Mexico markets separately. Evaluate market dynamics, competitive landscapes, and growth potential across individual North American countries.
      • Competitive Intelligence : Identify leading fertility clinics, technology providers, and service operators in North America. Benchmark your position against regional competitors and understand market consolidation trends.
      • Regulatory & Reimbursement Insights : Navigate North America's complex insurance coverage landscape and regulatory requirements. Understand reimbursement policies that directly impact market accessibility and revenue potential.
      • Strategic Growth Opportunities : Discover emerging segments, underserved geographic areas, and high-growth patient demographics. Develop targeted expansion strategies based on regional demand patterns and market gaps.

      Frequently asked questions

      What is the current size of the IVF market in North America?

      The In Vitro Fertilization market in North America was valued at $215.5 million in 2024 and is expected to grow to $361.9 million by 2029.

      What is the projected growth rate for North America's IVF market?

      North America's IVF market is projected to grow at a compound annual growth rate (CAGR) of 10.9% from 2024 to 2029.

      What factors are driving IVF market growth in North America?

      Key growth drivers in North America include rising infertility rates, delayed childbearing trends, improved insurance coverage, advanced healthcare infrastructure, and technological innovations in reproductive medicine.

      How does North America's IVF market compare to other regions?

      North America's IVF market benefits from superior healthcare infrastructure, higher reimbursement rates, stronger regulatory frameworks, and greater patient awareness compared to many other global regions.

      What technological advancements are impacting North America's IVF market?

      Advancements in embryo selection, cryopreservation techniques, genetic screening, and artificial intelligence-driven treatment optimization are enhancing success rates and driving market growth in North America.

      RESEARCH METHODOLOGY

      In this research, the utilization of both primary and secondary sources was done to a great extent. This included studying the factors affecting the industry to find out the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and strategies by key players.

      Secondary Research

      The secondary research process involves methods using directories, databases such as D&B Hoovers, Bloomberg Businessweek, Factiva, white papers, annual reports, company filings, investor presentations, and SEC filings, and collation of the database of industry leaders. This would help in fleshing out basic information on key players and market segmentation based upon the trends of the industry at various levels, major developments in the market, and technological perspectives pertaining to the in vitro fertilization market.

      Primary Research

      Primary research for this report featured interviews with a cross-section of sources from both the supply and demand sides to generate qualitative and quantitative data. On the supply side, there were primary sources from industries represented by CEOs, vice presidents, marketing and sales directors, regional sales managers, technology and innovation directors, and other key executives from leading companies and organizations in product therapy markets. Primary sources on the demand side included but were not limited to: embryologists, clinicians, procurement managers, purchase managers, department heads, and professionals from hospitals, fertility clinics, in vitro fertilization centers, and reference labs, among others. This primary research was hoped to validate market segmentation, identify key market players, and get an overview of the key trends and dynamics of the industry.

      A breakdown of the primary respondents is provided below:

      In Vitro Fertilization Market Size, and Share

      To know about the assumptions considered for the study, download the pdf brochure

      *Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

      Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1  billion, Tier 2 = <USD 500 million, and Tier 3 = <USD 100 million.

      Market Estimation Methodology

      This report also presents the key players' revenue share analysis for the size of the in vitro fertilization market. The identification of key market participants and insights about their revenues in the in vitro fertilization sector are gathered through phases of primary and secondary research. The secondary research process relied heavily on top players' annual and financial reports, while primary research involved highly exhaustive interviews with key opinion leaders, viz., CEOs, directors, and senior marketing executives.

      The methodology adopted to calculate the global market value was on a segment basis. These segmental revenues were then sourced through the revenue data of major solution and service providers. The steps involved in the process are

      • Draw up a list of key global players operating in the in vitro fertilization market. Map the annual revenues accrued by players from the in vitro fertilization market or nearest reported business unit/ product category.
      • It represents the current major share of the global market as of 2022, using revenue mapping of the key players.

      Extrapolation to the global value for the in vitro fertilization market. Global In vitro fertilization Market: Bottom-Up Approach

      In Vitro Fertilization Market Size, and Share

      To know about the assumptions considered for the study, Request for Free Sample Report

      Global In vitro fertilization Market : Top-Down Approach

      In Vitro Fertilization Market Size, and Share

      In Vitro Fertilization Market Size, and Share

      Data Triangulation

      The in vitro fertilization market was segmented under various categories and subcategories using the above-mentioned methodology. Thereafter, proper data triangulation and the market segmentation process are carried out to further increase the accuracy of the data for each segment. Factors and trends from both the demand and supply sides were studied. Rigorous employment of both top-down and bottom-up approaches provided the result of the analysis of the in vitro fertilization market.

      Market Definition

      The in vitro fertilization market refers to the global landscape of Assisted Reproductive Technologies services and products that help a person or a couple conceive. It is a market that represents fertility clinics, hospitals, and even research institutions that provide in vitro fertilization treatments and related services, including medical devices, laboratory equipment, drugs, and consumables used for in vitro fertilization procedures. It also includes the diagnostic tests carried out prior to and in the course of in vitro fertilization, genetic screening technologies, and cryopreservation services. In vitro fertilization market has been used as a generic term describing the portfolio of diverse technologies, services, and products relating to the alleviation of infertility and the promotion of reproductive health.

      Key Stakeholders

      • Manufacturers and distributors of In vitro fertilization devices
      • Healthcare institutions (Hospitals and clinics)
      • Surgical centers
      • Healthcare institutions (hospitals and cardiac centers)
      • Research institutions
      • Clinical research organizations
      • Academic Medical Centers and Universities
      • Reference labs
      • Clinical research organizations
      • Accountable Care Organizations (ACOs)
      • Research and consulting firms
      • Contract research organizations (CROs) and contract manufacturing organizations (CMOs)
      • Academic medical centers and universities
      • Market research and consulting firms
      • Surgery Centers
      • Group Purchasing Organizations (GPOs)
      • Medical Research Laboratories
      • Academic Medical Centers and Universities

      Objectives of the Study

      • Define, describe, and forecast the In vitro fertilization market on Product, cycle, procedure, end user and region.
      • Analyze opportunities in the market for stakeholders and details of the competitive landscape for market leaders.
      • Detailed information regarding major factors influencing the market growth.
      • Analysis of the micro markets with respect to individual growth trends, prospects, and contribution to the total market.
      • Tracking and analysis of competitive developments such as new product launches and approvals, agreements, partnerships, expansions, acquisitions, and collaborations in the in vitro fertilization market.
      • Description of key companies operating in the market along with their market share analysis and core competencies

      Available Customizations

      With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global In vitro fertilization market

      Product Analysis

      • Product matrix, which gives a detailed comparison of the product portfolios of the top 5 companies.

      Company Information

      • Detailed analysis and profiling of additional market players (up to 5)

      Geographic Analysis

      • Further breakdown of the Rest of Europe's In vitro fertilization market: Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal among other
      • Further breakdown of the Rest of Asia Pacific In vitro fertilization market Singapore, Taiwan, New Zealand, Philippines, Malaysia, and other APAC countries
      • Further breakdown of the Rest of the world In vitro fertilization market: Latin America, MEA, and Africa

      Get the Full In Vitro Fertilization Market Report

      Full forecast, segment splits, and company analysis for all In Vitro Fertilization Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status